Compare Stocks → Gold Mania (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:IBBNYSEARCA:VHTNYSEARCA:XBINYSEARCA:XLV Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBBiShares Biotechnology ETF$132.96+1.8%$133.61$111.83▼$141.16$7.31B0.751.70 million shs1.80 million shsVHTVanguard Health Care ETF$258.02+0.3%$262.89$222.27▼$271.53$17.32B0.61188,329 shs86,504 shsXBISPDR S&P Biotech ETF$89.98+1.9%$92.07$63.80▼$103.52$6.86B1.1111.70 million shs11.24 million shsXLVHealth Care Select Sector SPDR Fund$140.83+0.2%$143.57$122.59▼$148.27$38.11B0.558.65 million shs8.54 million shs5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBBiShares Biotechnology ETF0.00%+5.12%+1.01%-1.22%+1.74%VHTVanguard Health Care ETF-0.01%+1.06%-0.83%-0.57%+4.94%XBISPDR S&P Biotech ETF0.00%+7.77%+0.55%+2.28%+8.14%XLVHealth Care Select Sector SPDR Fund+0.01%+0.62%-0.79%-0.82%+5.52%Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AVHTVanguard Health Care ETFN/AN/AN/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/AN/AN/AN/AXLVHealth Care Select Sector SPDR FundN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIBBiShares Biotechnology ETF0.00N/A$157.9018.75% UpsideVHTVanguard Health Care ETF0.00N/A$288.2511.72% UpsideXBISPDR S&P Biotech ETF0.00N/A$117.4830.56% UpsideXLVHealth Care Select Sector SPDR Fund0.00N/A$156.9011.41% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AVHTVanguard Health Care ETFN/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/AN/AXLVHealth Care Select Sector SPDR FundN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIBBiShares Biotechnology ETFN/AN/A0.00∞N/AN/AN/AN/AN/AVHTVanguard Health Care ETFN/AN/A23.22∞N/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/A11.47∞N/AN/AN/AN/AN/AXLVHealth Care Select Sector SPDR FundN/AN/A23.82∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIBBiShares Biotechnology ETF$0.410.31%N/AN/AN/AVHTVanguard Health Care ETF$3.301.28%N/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/AXLVHealth Care Select Sector SPDR Fund$1.991.41%N/AN/AN/ALatest XLV, VHT, IBB, and XBI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/20/2024IBBiShares Biotechnology ETFQuarterly$0.12603/21/20243/22/20243/27/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIBBiShares Biotechnology ETF62.45%VHTVanguard Health Care ETFN/AXBISPDR S&P Biotech ETFN/AXLVHealth Care Select Sector SPDR FundN/AInsider OwnershipCompanyInsider OwnershipIBBiShares Biotechnology ETFN/AVHTVanguard Health Care ETFN/AXBISPDR S&P Biotech ETFN/AXLVHealth Care Select Sector SPDR FundN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableIBBiShares Biotechnology ETFN/A54.95 millionN/AOptionableVHTVanguard Health Care ETFN/A67.14 millionN/ANot OptionableXBISPDR S&P Biotech ETFN/A76.22 millionN/ANot OptionableXLVHealth Care Select Sector SPDR FundN/A270.62 millionN/ANot OptionableXLV, VHT, IBB, and XBI HeadlinesSourceHeadline16 out of 24 health care companies beat topline numbers this week- Earnings scorecardmsn.com - May 4 at 6:09 PMETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlookzacks.com - May 1 at 12:01 PMCVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens? (XLV)marketbeat.com - April 30 at 9:25 AMWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?zacks.com - April 24 at 1:06 PMBeyond "Big Six:" Why Choose Non-Cyclical Sector ETFs?zacks.com - April 24 at 9:01 AMCapturing Consumer Spending on Health Care with XLVfinance.yahoo.com - April 22 at 9:36 AM3 Biotech Stocks Set to Double by 2028investorplace.com - April 20 at 6:15 AMUnitedHealth Rises on Q1 Earnings Beat: ETFs to Gainmsn.com - April 17 at 1:54 PMUnitedHealth Rises on Q1 Earnings Beat: ETFs to Gainzacks.com - April 17 at 12:11 PMJNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focuszacks.com - April 17 at 11:00 AMCiti’s Results Say This About The Stock Market (XLV)marketbeat.com - April 15 at 7:14 AM4 Sector ETFs & Stocks to Benefit From Hot Inflationzacks.com - April 11 at 3:11 PM3 High Dividend Stocks to Replace Lower Savings Yields Ahead (XLV)marketbeat.com - April 11 at 11:09 AM3 Sector ETFs & Stocks to Bet on March Jobs Datazacks.com - April 9 at 9:01 AMEXCLUSIVE: Pharma's Cloud Revolution — A $60B Market By 2030 With 1 Stock To Watchmarkets.businessinsider.com - March 28 at 10:10 AMShould You Invest in the Health Care Select Sector SPDR ETF (XLV)?zacks.com - March 25 at 7:20 AMNvidia's AI Tech Part of Novo Nordisk's New Supercomputer (XLV)marketbeat.com - March 24 at 1:53 PMHealth Care Select Sector SPDR ETFwsj.com - March 22 at 5:09 PMHealth Care Select Sector SPDR Fund (XLV)finance.yahoo.com - March 15 at 4:00 PMConsider an Equal Weight Strategy Amid Renewed Volatilityetftrends.com - March 15 at 12:16 PM4 Best Sector ETFs to Play Nowzacks.com - March 14 at 3:01 PMHealth Care Up as Sector Gathers Upward Momentum -- Health Care Roundupmarketwatch.com - March 9 at 12:54 AMbluebird bio Stock Signals Potential to be a Multi-bagger (XLV)marketbeat.com - February 29 at 9:57 AMBeyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expectmarkets.businessinsider.com - February 27 at 1:26 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackHow to Use Put Debit Spreads to Profit From Falling Stocks April 26, 2024 9:30 AMView How to Use Put Debit Spreads to Profit From Falling Stocks Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsCaterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesApril 25, 2024 10:36 AMView Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesIs Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?April 16, 2024 6:15 AMView Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?All Headlines Company DescriptionsiShares Biotechnology ETFNASDAQ:IBBiShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Vanguard Health Care ETFNYSEARCA:VHTVanguard Health Care ETF seeks to track the investment performance of the MSCI US Investable Market Health Care 25/50 Index, a benchmark of large-, mid-, and small-cap United States stocks in the health care sector, as classified under the Global Industry Classification Standard (GICS). This GICS sector is made up of two main industry groups. The first group includes companies that manufacture health care equipment and supplies or provide health care related services (such as distributors of health care products, providers of basic health care services, and owners and operators of health care facilities and organizations). The second group includes companies primarily involved in the research, development, production, and marketing of pharmaceuticals and biotechnology products. The Vanguard Group, Inc., through its Quantitative Equity Group, serves as the investment advisor of the Fund.SPDR S&P Biotech ETFNYSEARCA:XBISPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.Health Care Select Sector SPDR FundNYSEARCA:XLVHealth Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.